Scientific Reports (Mar 2023)

Retinal tissue and microvasculature loss in COVID-19 infection

  • Fritz Gerald P. Kalaw,
  • Alexandra Warter,
  • Melina Cavichini,
  • Darren Knight,
  • Alexandria Li,
  • Daniel Deussen,
  • Carlo Galang,
  • Anna Heinke,
  • Veronica Mendoza,
  • Shyamanga Borooah,
  • Sally L. Baxter,
  • Dirk-Uwe Bartsch,
  • Lingyun Cheng,
  • William R. Freeman

DOI
https://doi.org/10.1038/s41598-023-31835-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 8

Abstract

Read online

Abstract This cross-sectional study aimed to investigate the hypothesis that permanent capillary damage may underlie the long-term COVID-19 sequela by quantifying the retinal vessel integrity. Participants were divided into three subgroups; Normal controls who had not been affected by COVID-19, mild COVID-19 cases who received out-patient care, and severe COVID-19 cases requiring intensive care unit (ICU) admission and respiratory support. Patients with systemic conditions that may affect the retinal vasculature before the diagnosis of COVID-19 infection were excluded. Participants underwent comprehensive ophthalmologic examination and retinal imaging obtained from Spectral-Domain Optical Coherence Tomography (SD-OCT), and vessel density using OCT Angiography. Sixty-one eyes from 31 individuals were studied. Retinal volume was significantly decreased in the outer 3 mm of the macula in the severe COVID-19 group (p = 0.02). Total retinal vessel density was significantly lower in the severe COVID-19 group compared to the normal and mild COVID-19 groups (p = 0.004 and 0.0057, respectively). The intermediate and deep capillary plexuses in the severe COVID-19 group were significantly lower compared to other groups (p < 0.05). Retinal tissue and microvascular loss may be a biomarker of COVID-19 severity. Further monitoring of the retina in COVID-19-recovered patients may help further understand the COVID-19 sequela.